Evaluate the Efficacy and Safety of KI1107 in Patients Whose TG Level is Not Adequately Controlled With Rosuvastatin Calcium Monotherapy While LDL-C is Properly Controlled
Clinical trial NCT03026933 · COMPLETED
Trial details
- NCT number
- NCT03026933
- Sponsor
- Kuhnil Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2016-03-01
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.